Insider trades by month
US insider trades, June 2025
The 11,426 open-market buys and sales by US company CEOs, executives and directors filed in June 2025.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Director | T-Mobile USTMUS | Open-market sale10b5-1 plan | 25/06/26–25/06/30 | 25/06/30 | 209,520 sh12 trades | $234.19avg. | $49,066,894.17 | −0.0% |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
DNA XSONM | Open-market sale | 25/06/26–25/06/30 | 25/06/30 | 866,916 sh2 trades | $1.45avg. | $1,256,317.46 | −100.0% | |
Irwin GoldCo-chairman | Houlihan LokeyHLI | Open-market sale | 25/06/30 | 25/06/30 | 5,000 sh | $182.81 | $914,050 | −100.0% |
Netsol TechnologiesNTWK | Open-market buy | 25/06/30 | 25/06/30 | 4,950 sh | $3.11 | $15,394.5 | +0.5% | |
Kellogg W K Foundation10% Owner | Kellanova | Open-market sale10b5-1 plan | 25/06/30 | 25/06/30 | 114,583 sh | $79.37 | $9,094,452.71 | −0.2% |
Kellogg W. K. Foundation Trust10% Owner | Kellanova | Open-market sale10b5-1 plan | 25/06/30 | 25/06/30 | 114,583 sh | $79.37 | $9,094,452.71 | −0.2% |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
Francis D. GannonVice President | Royce Global TrustRGT | Open-market sale | 25/06/30 | 25/06/30 | 7,214 sh | $11.92 | $85,990.88 | −100.0% |
ArganAGX | Open-market sale | 25/06/27–25/06/30 | 25/06/30 | 11,655 sh2 trades | $221.76avg. | $2,584,599.87 | −18.7% | |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
Dolphin EntertainmentDLPN | Open-market buy10b5-1 plan | 25/06/30 | 25/06/30 | 4,400 sh | $1.13 | $4,972 | +1.9% | |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
T-Mobile USTMUS | Open-market sale10b5-1 plan | 25/06/26–25/06/30 | 25/06/30 | 209,520 sh12 trades | $234.19avg. | $49,066,894.17 | −0.0% | |
T-Mobile USTMUS | Open-market sale10b5-1 plan | 25/06/26–25/06/30 | 25/06/30 | 209,520 sh12 trades | $234.19avg. | $49,066,894.17 | −0.0% | |
Kymera TherapeuticsKYMR | Open-market buy | 25/06/30 | 25/06/30 | 655,500 sh2 trades | $44.00avg. | $28,842,000 | +12.0% | |
T-Mobile USTMUS | Open-market sale10b5-1 plan | 25/06/26–25/06/30 | 25/06/30 | 209,520 sh12 trades | $234.19avg. | $49,066,894.17 | −0.0% | |
| Open-market sale | 25/06/26–25/06/30 | 25/06/30 | 2,068 sh3 trades | $22.48avg. | $46,490.88 | −0.2% | ||
Arnold FrancesDirector | AlphabetGOOGL | Open-market sale10b5-1 plan | 25/06/30 | 25/06/30 | 121 sh | $180.72 | $21,867.12 | −0.7% |
Other months
- September 20262,606
- June 202620,298
- May 202614,504
- April 20269,432
- March 202614,721
- February 202610,638
- January 20267,844
- December 202512,093
- November 202511,751
- October 202513,072
- September 202513,090
- August 202514,381
- July 20258,748
- June 202511,426
- May 202511,415
- April 20256,792
- March 202512,399
- February 202510,686
- January 20258,151
- December 202416,069
- November 202416,983
- October 20248,518
- September 202410,511
- August 202414,013
- July 202410,847
- June 202412,704
- May 202412,649
- April 20248,608
- March 202417,622
- February 202413,916
- January 20249,748
- December 202314,239
- November 202312,685
- October 20236,365
- September 20239,845
- August 202312,892
- July 20237,232
- June 202311,204
- May 202313,009
- April 20235,870
- March 202313,084
- February 202311,300
- January 20238,626